Monday, November 2, 2026

How Daewoong’s Innovative Microneedle Patches Could Revolutionize Diabetes and Obesity Treatment

Daewoong Pharmaceutical is building facilities for microneedle drugs and accelerating commercialization of obesity and diabetes patches.

Penetrium’s Innovative Cancer Drug Enters Phase 2 Trials in the U.S.: What You Need to Know

Penetrium Bioscience is submitting an IND for Penetrium to start Phase 2 cancer trials in the U.S., leveraging prior safety data.

Kim Jong-un Sends New Year Greeting To Putin: “The Most Sincere Alliance Relationship”

Kim Jong Un sends New Year's greetings to Putin, highlighting the strong North Korea-Russia alliance and commitment to future cooperation.

News1

Author's Latest

Hugel Launches Letybo in India: What This Means for the Aesthetic Market in 2026

Hugel enters the Indian market with its botulinum toxin product Letybo, targeting a 9% share in the aesthetic sector this year.

Lunit Joins Global AI Consortium for Next-Gen Drug Development: What This Means for Precision Medicine

Lunit joins an AI consortium to enhance drug development through AI-driven pathology and biomarker analysis, collaborating with global firms.

Celltrion Group’s 2 Trillion KRW Investment: What It Means for Global Bio Manufacturing by 2032

Celltrion Group plans a 2 trillion KRW investment to enhance production capacity and establish a leading position in global biotech.

Celltrion Expands PFS Production Capacity to 70 Million: What This Means for the Global Market

Celltrion Pharmaceutical plans to invest 2 trillion KRW to expand its pre-filled syringe production capacity to meet global demand.

Regenerative Medicine Expanded to Four Diseases Including Knee Osteoarthritis; Medipost and CHA Biotech Seen as Potential Beneficiaries

The Korean government is easing regulations on regenerative medicine, boosting biotech, and enabling patient access to validated therapies.

From Preclinical Development to Licensing: JNPMEDI Aims to Accelerate K-Biotech Growth With AI

JNPMEDI emphasizes the need for Korea's biotech sector to enhance global commercialization and reduce clinical trial costs using AI.

NGeneBio Expands Blood Cancer Diagnostic Panel Supply to Seoul National University Bundang Hospital

NGeneBio expands its blood cancer diagnostic panel supply, achieving strong growth in South Korea and international markets.

AI Model Enables Detection of Breathing Abnormalities During Surgery Without Blood Draws

South Korean researchers developed an AI model for noninvasive monitoring of pediatric patients' arterial carbon dioxide during surgery.

“Can I Have a Baby Too?” Hospital Gives Hope to Mothers With Heart Valve Disease

A study highlights successful pregnancies for women with heart valve disease, emphasizing the need for multidisciplinary care and risk assessment.

How an 82-Year-Old Defied Odds: Successful Removal of Brainstem Cancer with Keyhole Surgery

An 82-year-old's brainstem tumor was successfully removed using minimally invasive surgery, restoring his motor function and independence.

How Celltrion’s Truxima Dominates the U.S. Rituximab Market: A 4-Month Winning Streak

Celltrion's Truxima leads the U.S. rituximab market for four months, gaining FDA interchangeability status, boosting growth prospects.

Breakthrough in MASH Treatment: How miRNA-10a Outperforms Resmetirom in Fat Reduction

RXBio's miRNA-10a shows superior efficacy over Resmetirom in treating MASH, reducing fat, fibrosis, and inflammation significantly.

How Peony Root Extract Reduces Inflammation: A Breakthrough in Gut-Brain Health

A study reveals Moutan Cortex extract may reduce intestinal inflammation and improve brain function, highlighting its potential for treating anxiety.

Neurophet AQUA AD Plus: The Innovative AI Tool Designated for Public Health in 2026

Neurophet's Alzheimer's treatment solution, Neurophet AQUA AD Plus, gains innovative product status, enhancing public procurement access.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.